{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T04:55:57Z","timestamp":1781672157256,"version":"3.54.5"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.eclinm.2026.103919","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:44Z","timestamp":1778198444000},"page":"103919","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Perinatal outcomes associated with antiretroviral therapy for pregnant women living with HIV: an umbrella review"],"prefix":"10.1016","volume":"95","author":[{"given":"Pippa Huete","family":"Boering","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3523-7457","authenticated-orcid":false,"given":"Joris","family":"Hemelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2026.103919_bib1","series-title":"2025 Global AIDS update","year":"2025"},{"key":"10.1016\/j.eclinm.2026.103919_bib2","series-title":"UNAIDS data","year":"2025"},{"key":"10.1016\/j.eclinm.2026.103919_bib3","series-title":"Recommendations for a public health approach","article-title":"Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection","author":"World Health","year":"2013"},{"key":"10.1016\/j.eclinm.2026.103919_bib4","series-title":"Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection","year":"2016"},{"key":"10.1016\/j.eclinm.2026.103919_bib5","series-title":"Consolidated guidelines on HIV prevention testing, treatment, service delivery and monitoring: recommendations for a public health approach","year":"2021"},{"key":"10.1016\/j.eclinm.2026.103919_bib6","series-title":"Recommendations for the use of antiretroviral drugs during pregnancy and interventions to reduce perinatal HIV transmission in the United States","year":"2025"},{"key":"10.1016\/j.eclinm.2026.103919_bib7","series-title":"EACS Guidelines v13.0","article-title":"Treatment of pregnant women living with HIV or women considering pregnancy","year":"2025"},{"issue":"11","key":"10.1016\/j.eclinm.2026.103919_bib8","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1111\/hiv.70091","article-title":"BHIVA guidelines on the management of HIV in pregnancy and the postpartum period 2025","volume":"26","author":"Byrne","year":"2025","journal-title":"HIV Med"},{"issue":"1","key":"10.1016\/j.eclinm.2026.103919_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3018(15)00207-6","article-title":"Perinatal outcomes associated with maternal HIV infection: a systematic review and meta-analysis","volume":"3","author":"Wedi","year":"2016","journal-title":"Lancet HIV"},{"issue":"12 Suppl 2","key":"10.1016\/j.eclinm.2026.103919_bib10","doi-asserted-by":"crossref","first-page":"S691","DOI":"10.1093\/infdis\/jiab494","article-title":"HIV, placental lesions, and adverse perinatal outcomes","volume":"224","author":"Maswime","year":"2021","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.eclinm.2026.103919_bib11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0165-0378(97)00018-1","article-title":"Immunologic activation during pregnancy: serial measurement of lymphocyte phenotype and serum activation molecules in HIV-infected and uninfected women","volume":"33","author":"Mikyas","year":"1997","journal-title":"J Reprod Immunol"},{"issue":"6","key":"10.1016\/j.eclinm.2026.103919_bib12","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1182\/blood-2010-07-298992","article-title":"Dysregulation of CD4+CD25+CD127lowFOXP3+ regulatory T cells in HIV-infected pregnant women","volume":"117","author":"Kolte","year":"2011","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.eclinm.2026.103919_bib13","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1055\/s-0035-1571199","article-title":"A worldwide epidemic: the problem and challenges of preterm birth in low- and middle-income countries","volume":"33","author":"Smid","year":"2016","journal-title":"Am J Perinatol"},{"issue":"2","key":"10.1016\/j.eclinm.2026.103919_bib14","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S2352-4642(21)00311-4","article-title":"Global, regional, and national causes of under-5 mortality in 2000-19: an updated systematic analysis with implications for the sustainable development goals","volume":"6","author":"Perin","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"issue":"10409","key":"10.1016\/j.eclinm.2026.103919_bib15","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0140-6736(23)00878-4","article-title":"National, regional, and global estimates of preterm birth in 2020, with trends from 2010: a systematic analysis","volume":"402","author":"Ohuma","year":"2023","journal-title":"Lancet"},{"issue":"10389","key":"10.1016\/j.eclinm.2026.103919_bib16","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0140-6736(23)00522-6","article-title":"Small babies, big risks: global estimates of prevalence and mortality for vulnerable newborns to accelerate change and improve counting","volume":"401","author":"Lawn","year":"2023","journal-title":"Lancet"},{"issue":"10431","key":"10.1016\/j.eclinm.2026.103919_bib17","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0140-6736(23)01198-4","article-title":"National, regional, and global estimates of low birthweight in 2020, with trends from 2000: a systematic analysis","volume":"403","author":"Okwaraji","year":"2024","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.eclinm.2026.103919_bib18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s43856-023-00331-8","article-title":"Adverse perinatal outcomes attributable to HIV in Sub-Saharan Africa from 1990 to 2020: systematic review and meta-analyses","volume":"3","author":"Murray","year":"2023","journal-title":"Commun Med"},{"key":"10.1016\/j.eclinm.2026.103919_bib19","series-title":"Transforming our world: the 2030 agenda for sustainable development","year":"2015"},{"issue":"2","key":"10.1016\/j.eclinm.2026.103919_bib20","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1016\/S2214-109X(21)00515-5","article-title":"Global, regional, and national trends in under-5 mortality between 1990 and 2019 with scenario-based projections until 2030: a systematic analysis by the UN Inter-agency Group for Child Mortality Estimation","volume":"10","author":"Sharrow","year":"2022","journal-title":"Lancet Glob Health"},{"issue":"7","key":"10.1016\/j.eclinm.2026.103919_bib21","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/infdis\/jiv390","article-title":"Antiretroviral therapy and adverse pregnancy outcome: the elephant in the room?","volume":"213","author":"Mofenson","year":"2016","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.eclinm.2026.103919_bib22","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1016\/S1473-3099(22)00687-9","article-title":"Understanding clinical outcome measures reported in HIV pregnancy studies involving antiretroviral-naive and antiretroviral-experienced women","volume":"23","author":"Eke","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.eclinm.2026.103919_bib23","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJMra2212877","article-title":"Antiretroviral therapy and adverse pregnancy outcomes in people living with HIV","volume":"388","author":"Eke","year":"2023","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.eclinm.2026.103919_bib24","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1080\/17512433.2017.1390428","article-title":"Darunavir for use in pregnant women with HIV","volume":"10","author":"Pope","year":"2017","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"8","key":"10.1016\/j.eclinm.2026.103919_bib25","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1471-0528.1998.tb10227.x","article-title":"The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta-analysis","volume":"105","author":"Brocklehurst","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.eclinm.2026.103919_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/QAI.0000000000001770","article-title":"Use of antiretroviral therapy during pregnancy and adverse birth outcomes among women living with HIV-1 in Low- and middle-income countries: a systematic review","volume":"79","author":"Saleska","year":"2018","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"10.1016\/j.eclinm.2026.103919_bib27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2217\/fvl-2018-0213","article-title":"Pregnancy outcomes and effects of antiretroviral drugs in HIV-positive pregnant women: a systematic review","volume":"14","author":"Abdi","year":"2019","journal-title":"Future Virol"},{"issue":"1","key":"10.1016\/j.eclinm.2026.103919_bib28","first-page":"31","article-title":"Antiretroviral therapy and pregnancy outcomes in developing countries: a systematic review","volume":"3","author":"Alemu","year":"2015","journal-title":"Int J MCH AIDS"},{"issue":"1","key":"10.1016\/j.eclinm.2026.103919_bib29","first-page":"38","article-title":"Safety and efficacy of lopinavir\/ritonavir during pregnancy: a systematic review","volume":"15","author":"Pasley","year":"2013","journal-title":"AIDS Rev"},{"key":"10.1016\/j.eclinm.2026.103919_bib30","doi-asserted-by":"crossref","first-page":"8528","DOI":"10.1038\/srep08528","article-title":"Efficacy and biological safety of lopinavir\/ritonavir based anti-retroviral therapy in HIV-1-infected patients: a meta-analysis of randomized controlled trials","volume":"5","author":"Huang","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.eclinm.2026.103919_bib31","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12978-016-0149-5","article-title":"Is protease inhibitors based antiretroviral therapy during pregnancy associated with an increased risk of preterm birth? Systematic review and a meta-analysis","volume":"13","author":"Mesfin","year":"2016","journal-title":"Reprod Health"},{"issue":"6","key":"10.1016\/j.eclinm.2026.103919_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198447","article-title":"Comparative safety and effectiveness of perinatal antiretroviral therapies for HIV-infected women and their children: systematic review and network meta-analysis including different study designs","volume":"13","author":"Veroniki","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.eclinm.2026.103919_bib33","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/QAD.0000000000001313","article-title":"Tenofovir disoproxil fumarate safety for women and their infants during pregnancy and breastfeeding","volume":"31","author":"Mofenson","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.eclinm.2026.103919_bib34","series-title":"Cochrane handbook for systematic reviews of interventions","author":"Higgins","year":"2019"},{"key":"10.1016\/j.eclinm.2026.103919_bib35","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.eclinm.2026.103919_bib36","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-070849","article-title":"Reporting guideline for overviews of reviews of healthcare interventions: development of the PRIOR statement","volume":"378","author":"Gates","year":"2022","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.eclinm.2026.103919_bib37","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1097\/QAD.0000000000002593","article-title":"Adverse perinatal outcomes associated with antiretroviral therapy regimens: systematic review and network meta-analysis","volume":"34","author":"Tshivuila-Matala","year":"2020","journal-title":"AIDS"},{"issue":"9946","key":"10.1016\/j.eclinm.2026.103919_bib38","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0140-6736(14)60932-6","article-title":"International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st Project","volume":"384","author":"Villar","year":"2014","journal-title":"Lancet"},{"issue":"10389","key":"10.1016\/j.eclinm.2026.103919_bib39","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/S0140-6736(23)00354-9","article-title":"Small vulnerable newborns- big potential for impact","volume":"401","author":"Ashorn","year":"2023","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.eclinm.2026.103919_bib40","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/jrsm.1390","article-title":"Examining overlap of included studies in meta-reviews: guidance for using the corrected covered area index","volume":"11","author":"Hennessy","year":"2020","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.eclinm.2026.103919_bib41","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.eclinm.2026.103919_bib42","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"7650","key":"10.1016\/j.eclinm.2026.103919_bib43","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.eclinm.2026.103919_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1323813","article-title":"Comparative risk of adverse perinatal outcomes associated with classes of antiretroviral therapy in pregnant women living with HIV: systematic review and meta-analysis","volume":"11","author":"Beck","year":"2024","journal-title":"Front Med"},{"issue":"5","key":"10.1016\/j.eclinm.2026.103919_bib45","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/QAD.0000000000004104","article-title":"Perinatal outcomes among pregnant women with HIV initiating antiretroviral therapy preconception and antenatally","volume":"39","author":"Boering","year":"2025","journal-title":"AIDS"},{"key":"10.1016\/j.eclinm.2026.103919_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101368","article-title":"Adverse perinatal outcomes associated with protease inhibitor-based antiretroviral therapy in pregnant women living with HIV: a systematic review and meta-analysis","volume":"46","author":"Cowdell","year":"2022","journal-title":"eClinicalMedicine"},{"issue":"6","key":"10.1016\/j.eclinm.2026.103919_bib47","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.cmi.2025.01.014","article-title":"Association of nucleoside reverse transcriptase inhibitors with adverse perinatal outcomes in pregnant women living with HIV: systematic review and meta-analysis","volume":"31","author":"Cowdell","year":"2025","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.eclinm.2026.103919_bib48","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/QAD.0000000000004032","article-title":"Adverse perinatal outcomes associated with different classes of antiretroviral drugs in pregnant women living with HIV: a systematic review and meta-analysis","volume":"39","author":"Hey","year":"2025","journal-title":"AIDS"},{"issue":"10","key":"10.1016\/j.eclinm.2026.103919_bib49","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1097\/QAD.0000000000003248","article-title":"Adverse perinatal outcomes associated with HAART and monotherapy","volume":"36","author":"Portwood","year":"2022","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.eclinm.2026.103919_bib50","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/hiv.13326","article-title":"Adverse perinatal outcomes associated with timing of initiation of antiretroviral therapy: systematic review and meta-analysis","volume":"24","author":"Sexton","year":"2023","journal-title":"HIV Med"},{"issue":"1","key":"10.1016\/j.eclinm.2026.103919_bib51","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2352-3018(16)30195-3","article-title":"Timing of initiation of antiretroviral therapy and adverse pregnancy outcomes: a systematic review and meta-analysis","volume":"4","author":"Uthman","year":"2017","journal-title":"Lancet HIV"},{"issue":"5","key":"10.1016\/j.eclinm.2026.103919_bib54","doi-asserted-by":"crossref","first-page":"e322","DOI":"10.1016\/S2352-3018(20)30038-2","article-title":"Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial","volume":"7","author":"Jo\u00e3o","year":"2020","journal-title":"Lancet HIV"},{"issue":"5","key":"10.1016\/j.eclinm.2026.103919_bib53","doi-asserted-by":"crossref","first-page":"e332","DOI":"10.1016\/S2352-3018(20)30050-3","article-title":"Dolutegravir versus efavirenz in women starting HIV therapy in late pregnancy (DolPHIN-2): an open-label, randomised controlled trial","volume":"7","author":"Kintu","year":"2020","journal-title":"Lancet HIV"},{"issue":"10281","key":"10.1016\/j.eclinm.2026.103919_bib52","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/S0140-6736(21)00314-7","volume":"397","author":"Lockman","year":"2021","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.eclinm.2026.103919_bib55","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/QAI.0000000000000465","article-title":"Abacavir and lamivudine exposures during pregnancy and non-defect adverse pregnancy outcomes: data from the antiretroviral pregnancy registry","volume":"68","author":"Vannappagari","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eclinm.2026.103919_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102532","article-title":"Perinatal outcomes associated with pre-exposure prophylaxis for HIV prevention during pregnancy: a systematic review and meta-analysis","volume":"70","author":"Erlwanger","year":"2024","journal-title":"eClinicalMedicine"},{"issue":"5","key":"10.1016\/j.eclinm.2026.103919_bib57","doi-asserted-by":"crossref","first-page":"e332","DOI":"10.1016\/S2352-3018(23)00051-6","article-title":"Long-acting antiretrovirals and HIV treatment adherence","volume":"10","author":"Nachega","year":"2023","journal-title":"Lancet HIV"},{"issue":"4","key":"10.1016\/j.eclinm.2026.103919_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3018(17)30046-2","article-title":"Preconception ART and preterm birth: real effect or selection bias?","volume":"4","author":"Stringer","year":"2017","journal-title":"Lancet HIV"},{"key":"10.1016\/j.eclinm.2026.103919_bib59","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b5087","article-title":"Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes","volume":"340","author":"L\u00e9vesque","year":"2010","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.eclinm.2026.103919_bib60","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1600-0897.2010.00836.x","article-title":"Review ARTICLE: the immune system in pregnancy: a unique complexity","volume":"63","author":"Mor","year":"2010","journal-title":"Am J Reprod Immunol"},{"issue":"5","key":"10.1016\/j.eclinm.2026.103919_bib61","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/infdis\/170.5.1134","article-title":"Mother-to-child transmission of human immunodeficiency virus type 1: report from the Nairobi Study","volume":"170","author":"Datta","year":"1994","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.eclinm.2026.103919_bib62","first-page":"1125","article-title":"The association between maternal HIV-1 infection and pregnancy outcomes in Dar es Salaam, Tanzania","volume":"108","author":"Coley","year":"2001","journal-title":"BJOG"},{"issue":"1","key":"10.1016\/j.eclinm.2026.103919_bib63","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/imr.12079","article-title":"HIV-associated chronic immune activation","volume":"254","author":"Paiardini","year":"2013","journal-title":"Immunol Rev"},{"issue":"1","key":"10.1016\/j.eclinm.2026.103919_bib64","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-69966-0","article-title":"Innate lymphoid cells are reduced in pregnant HIV positive women and are associated with preterm birth","volume":"10","author":"Akoto","year":"2020","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.eclinm.2026.103919_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235162","article-title":"\u03b3\u03b4 T cell frequencies are altered in HIV positive pregnant South African women and are associated with preterm birth","volume":"15","author":"Akoto","year":"2020","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.eclinm.2026.103919_bib66","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s15010-021-01619-4","article-title":"CD4\/CD8 ratio in pregnant women with HIV and its association with pregnancy outcome: data from a national study in Italy","volume":"49","author":"Floridia","year":"2021","journal-title":"Infection"},{"issue":"1","key":"10.1016\/j.eclinm.2026.103919_bib67","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/infdis\/jiu393","article-title":"HIV protease inhibitor use during pregnancy is associated with decreased progesterone levels, suggesting a potential mechanism contributing to fetal growth restriction","volume":"211","author":"Papp","year":"2015","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.eclinm.2026.103919_bib68","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1016\/S2352-3018(21)00249-6","article-title":"Protease inhibitor-based antiretroviral therapy in pregnancy: effects on hormones, placenta, and decidua","volume":"9","author":"Dunk","year":"2022","journal-title":"Lancet HIV"},{"issue":"12","key":"10.1016\/j.eclinm.2026.103919_bib69","doi-asserted-by":"crossref","first-page":"e868","DOI":"10.1016\/S2352-3018(22)00249-1","article-title":"Two-drug regimens for HIV treatment","volume":"9","author":"Gibas","year":"2022","journal-title":"Lancet HIV"},{"issue":"Suppl 2","key":"10.1016\/j.eclinm.2026.103919_bib70","article-title":"Approaches to accelerating the study of new antiretrovirals in pregnancy","volume":"25 Suppl 2","author":"Abrams","year":"2022","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.eclinm.2026.103919_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103515","article-title":"Comparative growth of children who are HIV-exposed and uninfected with those who are HIV-unexposed and uninfected at age 1 and 2 years in South Africa: a prospective cohort study","volume":"89","author":"Carlqvist","year":"2025","journal-title":"eClinicalMedicine"},{"issue":"6","key":"10.1016\/j.eclinm.2026.103919_bib72","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S2352-4642(22)00071-2","article-title":"Early neurodevelopment of HIV-exposed uninfected children in the era of antiretroviral therapy: a systematic review and meta-analysis","volume":"6","author":"Wedderburn","year":"2022","journal-title":"Lancet Child Adolesc Health"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026001677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026001677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T04:39:01Z","timestamp":1781671141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537026001677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":72,"alternative-id":["S2589537026001677"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.103919","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perinatal outcomes associated with antiretroviral therapy for pregnant women living with HIV: an umbrella review","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.103919","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103919"}}